Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes
In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors speci...
Gespeichert in:
Veröffentlicht in: | The Journal of experimental medicine 1999-08, Vol.190 (4), p.577-584 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 584 |
---|---|
container_issue | 4 |
container_start_page | 577 |
container_title | The Journal of experimental medicine |
container_volume | 190 |
creator | Fossati, G Cooke, A Papafio, R Q Haskins, K Stockinger, B |
description | In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy. |
doi_str_mv | 10.1084/jem.190.4.577 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2195608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17319557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</originalsourceid><addsrcrecordid>eNqFkU1LAzEQhoMoWj-OXiUnb1uT3WSTXAQRv6DgpR4lZLOTNdImNdkK_ntTWkRPngZmHl7e4UHonJIpJZJdvcNyShWZsikXYg9NKGekUryR-2hCSF1XlBBxhI5zfieEMsbbQ3RECWOK13KCXufJDwMkHwZscAYbQ4_n2MJigRNYWI0x4Rhw700HYxwgeLu7Z2xNwKsEnxBG7EO_tqMvaHQ7GvIpOnBmkeFsN0_Qy_3d_Paxmj0_PN3ezCrLKBurvu-YEaphrrVO8M6JmlBlXEd7AWUnWqdqkLzn4KxVtJO8bomRkomOKSmbE3S9zV2tuyX0thRKZqFXyS9N-tLReP33EvybHuKnrqniLdkEXO4CUvxYQx710ufNkyZAXGfdKiVqwdi_IBVNieSigNUWtCnmnMD9tKFEb8zpYk4Xc5rpYq7wF79f-EVvVTXfSSOWig</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17319557</pqid></control><display><type>article</type><title>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Fossati, G ; Cooke, A ; Papafio, R Q ; Haskins, K ; Stockinger, B</creator><creatorcontrib>Fossati, G ; Cooke, A ; Papafio, R Q ; Haskins, K ; Stockinger, B</creatorcontrib><description>In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.190.4.577</identifier><identifier>PMID: 10449528</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Adoptive Transfer ; Animals ; Blood Glucose - analysis ; Clonal Anergy ; Complement C5 - genetics ; Complement C5 - immunology ; Diabetes Mellitus, Type 1 - immunology ; Diabetes Mellitus, Type 1 - prevention & control ; H-2 Antigens ; Homeodomain Proteins - genetics ; Homeodomain Proteins - immunology ; Islets of Langerhans - immunology ; Mice ; Mice, Inbred NOD ; Mice, Transgenic ; Models, Immunological ; Original ; Receptors, Antigen, T-Cell ; Receptors, Antigen, T-Cell, alpha-beta ; Spleen - cytology ; Spleen - immunology ; T-Lymphocytes - immunology</subject><ispartof>The Journal of experimental medicine, 1999-08, Vol.190 (4), p.577-584</ispartof><rights>1999 The Rockefeller University Press 1999 The Rockefeller University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</citedby><cites>FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195608/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195608/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10449528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fossati, G</creatorcontrib><creatorcontrib>Cooke, A</creatorcontrib><creatorcontrib>Papafio, R Q</creatorcontrib><creatorcontrib>Haskins, K</creatorcontrib><creatorcontrib>Stockinger, B</creatorcontrib><title>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.</description><subject>Adoptive Transfer</subject><subject>Animals</subject><subject>Blood Glucose - analysis</subject><subject>Clonal Anergy</subject><subject>Complement C5 - genetics</subject><subject>Complement C5 - immunology</subject><subject>Diabetes Mellitus, Type 1 - immunology</subject><subject>Diabetes Mellitus, Type 1 - prevention & control</subject><subject>H-2 Antigens</subject><subject>Homeodomain Proteins - genetics</subject><subject>Homeodomain Proteins - immunology</subject><subject>Islets of Langerhans - immunology</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Mice, Transgenic</subject><subject>Models, Immunological</subject><subject>Original</subject><subject>Receptors, Antigen, T-Cell</subject><subject>Receptors, Antigen, T-Cell, alpha-beta</subject><subject>Spleen - cytology</subject><subject>Spleen - immunology</subject><subject>T-Lymphocytes - immunology</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1LAzEQhoMoWj-OXiUnb1uT3WSTXAQRv6DgpR4lZLOTNdImNdkK_ntTWkRPngZmHl7e4UHonJIpJZJdvcNyShWZsikXYg9NKGekUryR-2hCSF1XlBBxhI5zfieEMsbbQ3RECWOK13KCXufJDwMkHwZscAYbQ4_n2MJigRNYWI0x4Rhw700HYxwgeLu7Z2xNwKsEnxBG7EO_tqMvaHQ7GvIpOnBmkeFsN0_Qy_3d_Paxmj0_PN3ezCrLKBurvu-YEaphrrVO8M6JmlBlXEd7AWUnWqdqkLzn4KxVtJO8bomRkomOKSmbE3S9zV2tuyX0thRKZqFXyS9N-tLReP33EvybHuKnrqniLdkEXO4CUvxYQx710ufNkyZAXGfdKiVqwdi_IBVNieSigNUWtCnmnMD9tKFEb8zpYk4Xc5rpYq7wF79f-EVvVTXfSSOWig</recordid><startdate>19990816</startdate><enddate>19990816</enddate><creator>Fossati, G</creator><creator>Cooke, A</creator><creator>Papafio, R Q</creator><creator>Haskins, K</creator><creator>Stockinger, B</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990816</creationdate><title>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</title><author>Fossati, G ; Cooke, A ; Papafio, R Q ; Haskins, K ; Stockinger, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-ddb4a7934f6cf75bf72019afb1d7ef6c76f92e85d5efcc91b85260a8847b49883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adoptive Transfer</topic><topic>Animals</topic><topic>Blood Glucose - analysis</topic><topic>Clonal Anergy</topic><topic>Complement C5 - genetics</topic><topic>Complement C5 - immunology</topic><topic>Diabetes Mellitus, Type 1 - immunology</topic><topic>Diabetes Mellitus, Type 1 - prevention & control</topic><topic>H-2 Antigens</topic><topic>Homeodomain Proteins - genetics</topic><topic>Homeodomain Proteins - immunology</topic><topic>Islets of Langerhans - immunology</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Mice, Transgenic</topic><topic>Models, Immunological</topic><topic>Original</topic><topic>Receptors, Antigen, T-Cell</topic><topic>Receptors, Antigen, T-Cell, alpha-beta</topic><topic>Spleen - cytology</topic><topic>Spleen - immunology</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fossati, G</creatorcontrib><creatorcontrib>Cooke, A</creatorcontrib><creatorcontrib>Papafio, R Q</creatorcontrib><creatorcontrib>Haskins, K</creatorcontrib><creatorcontrib>Stockinger, B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fossati, G</au><au>Cooke, A</au><au>Papafio, R Q</au><au>Haskins, K</au><au>Stockinger, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>1999-08-16</date><risdate>1999</risdate><volume>190</volume><issue>4</issue><spage>577</spage><epage>584</epage><pages>577-584</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>In this paper, we test the hypothesis that triggering of a second T cell receptor (TCR) expressed on diabetogenic T cells might initiate the onset of diabetes. A cross between two TCR-transgenic strains, the BDC2.5 strain that carries diabetogenic TCRs and the A18 strain that carries receptors specific for C5, was set up to monitor development of diabetes after activation through the C5 TCR. F1 BDC2. 5 x A18 mice developed diabetes spontaneously beyond 3-4 mo of age. Although their T cells express both TCRs constitutively, the A18 receptor is expressed at extremely low levels. In vitro activation of dual TCR T cells followed by adoptive transfer into neonatal or adult F1 mice resulted in diabetes onset and death within 10 d after transfer. In contrast, in vivo immunization of F1 mice with different forms of C5 antigen not only failed to induce diabetes but protected mice from the spontaneous onset of diabetes. We propose that antigenic stimulation of cells with low levels of TCR produces signals inadequate for full activation, resulting instead in anergy.</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>10449528</pmid><doi>10.1084/jem.190.4.577</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1007 |
ispartof | The Journal of experimental medicine, 1999-08, Vol.190 (4), p.577-584 |
issn | 0022-1007 1540-9538 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2195608 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Adoptive Transfer Animals Blood Glucose - analysis Clonal Anergy Complement C5 - genetics Complement C5 - immunology Diabetes Mellitus, Type 1 - immunology Diabetes Mellitus, Type 1 - prevention & control H-2 Antigens Homeodomain Proteins - genetics Homeodomain Proteins - immunology Islets of Langerhans - immunology Mice Mice, Inbred NOD Mice, Transgenic Models, Immunological Original Receptors, Antigen, T-Cell Receptors, Antigen, T-Cell, alpha-beta Spleen - cytology Spleen - immunology T-Lymphocytes - immunology |
title | Triggering a second T cell receptor on diabetogenic T cells can prevent induction of diabetes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T23%3A32%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Triggering%20a%20second%20T%20cell%20receptor%20on%20diabetogenic%20T%20cells%20can%20prevent%20induction%20of%20diabetes&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Fossati,%20G&rft.date=1999-08-16&rft.volume=190&rft.issue=4&rft.spage=577&rft.epage=584&rft.pages=577-584&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.190.4.577&rft_dat=%3Cproquest_pubme%3E17319557%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17319557&rft_id=info:pmid/10449528&rfr_iscdi=true |